SWEDISH ORPHAN/S (OTCMKTS:SWTUY – Get Free Report)’s share price fell 1.2% during trading on Monday . The company traded as low as $24.38 and last traded at $24.38. 200 shares traded hands during trading, a decline of 88% from the average session volume of 1,665 shares. The stock had previously closed at $24.67.
SWEDISH ORPHAN/S Stock Down 1.2%
The firm has a 50-day moving average of $24.38 and a two-hundred day moving average of $24.38. The company has a market capitalization of $6.64 billion, a PE ratio of 48.76, a PEG ratio of 1.30 and a beta of 1.81.
About SWEDISH ORPHAN/S
Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B.
See Also
- Five stocks we like better than SWEDISH ORPHAN/S
- How Investors Can Find the Best Cheap Dividend Stocks
- UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?
- Golden Cross Stocks: Pattern, Examples and Charts
- What Ray Dalio’s Latest Moves Tell Investors
- Where Do I Find 52-Week Highs and Lows?
- Amazon: Why May Is the Last Month to Get the Stock at a Discount
Receive News & Ratings for SWEDISH ORPHAN/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWEDISH ORPHAN/S and related companies with MarketBeat.com's FREE daily email newsletter.
